AI-generated summary
The authors evaluated hydroquinone 4% cream, 30% trichloroacetic acid peeling, and frequency-doubled Q-switched Nd:YAG laser therapy in 45 Egyptian patients with moderate-to-severe melasma over an average of 6 months, using the MASI score. Topical hydroquinone showed the greatest improvement compared with the other treatments, and the laser and peeling groups did not differ significantly from each other.
- Participants
- 45
- Who or what was studied
- 45 Egyptian patients with moderate-to-severe melasma, mostly skin types IV-V
- Limits stated in the abstract
- The abstract does not describe a control group or randomization, and the study covers a single population over an average of 6 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.